Burkhard Tönshoff
Research Subjects
Research Interests
Burkhard Tönshoff has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Otto Mehls
Boston Children s Hospital
4 shared publications- Franz Schaefer
Pediatric Nephrology Division, Heidelberg University Hospital, Heidelberg, Germany
3 shared publications Daniela Kiepe
University Children’s Hospital
2 shared publications- Dieter Haffner
Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany
2 shared publications - Elke Wühl
Universitätsklinikum Heidelberg
2 shared publications Lothar B Zimmerhackl
2 shared publications
Latest Publications
- 1 October 2015
- Vol. 13 (5) , 413-20
Long-Term Follow-Up of Kidney Transplant Recipients With Polycystic Kidney Disease.
Patients with polycystic kidney disease are candidates for kidney transplant. We report the results of our single center study of 250 first transplant recipients with polycystic kidney disease (autosomal dominant [64%], medullary cystic [16%], autosomal recessive [6%], and nonspecified [14%]). Patient groups were divided and analyzed according to the origin of the graft (deceased donor or living donor). We also analyzed demographic data of donors and recipients, waiting time, duration of dialysis, transfusion, nephrectomy, hospitalization, morbidities, and graft and patient survival. The study was approved by the Ethical Review Committee of the Institute. All of the protocols conformed to the ethical guidelines of the 1975 Helsinki Declaration. The deceased-donor group comprised 79% and the living-donor group comprised 21% of the cases. Nephrectomy was performed on 21% of the recipients. The deceased-donor group showed significantly higher values than the living-donor group regarding rate of hemodialysis (82% vs 68%), duration of dialysis (1571 vs 1002 days), waiting time (1129 vs 33 days), and blood transfusions (45% vs 27%). In deceased-donor versus living-donor transplant recipients, surgical complications included arterial stenosis (1% vs 0%), venous thrombosis (1% vs 0%), urine leakage (0.5% vs 1.9%), ureteral stenosis (0.5% vs 0%), reflux (0% vs 1.9%), lymphocele (11.7% vs 8.1%), and hernia (5.2% vs 8.1%), with no statistically significant differences shown between the groups. The living-donor group had graft and patient survival rates as high as the deceased-donor group. The low rate of morbidity and excellent survival rates make kidney transplant an excellent option for patients with polycystic kidney disease. Although fear of future appearance of polycystic kidney disease may reduce the rate of related living donors, our study showed that graft and patient survival rates in the living-donor group were as high as in the deceased-donor group.
- 1 October 2015
- Vol. 13 (5) , 413-20
Long-Term Follow-Up of Kidney Transplant Recipients With Polycystic Kidney Disease.
Patients with polycystic kidney disease are candidates for kidney transplant. We report the results of our single center study of 250 first transplant recipients with polycystic kidney disease (autosomal dominant [64%], medullary cystic [16%], autosomal recessive [6%], and nonspecified [14%]). Patient groups were divided and analyzed according to the origin of the graft (deceased donor or living donor). We also analyzed demographic data of donors and recipients, waiting time, duration of dialysis, transfusion, nephrectomy, hospitalization, morbidities, and graft and patient survival. The study was approved by the Ethical Review Committee of the Institute. All of the protocols conformed to the ethical guidelines of the 1975 Helsinki Declaration. The deceased-donor group comprised 79% and the living-donor group comprised 21% of the cases. Nephrectomy was performed on 21% of the recipients. The deceased-donor group showed significantly higher values than the living-donor group regarding rate of hemodialysis (82% vs 68%), duration of dialysis (1571 vs 1002 days), waiting time (1129 vs 33 days), and blood transfusions (45% vs 27%). In deceased-donor versus living-donor transplant recipients, surgical complications included arterial stenosis (1% vs 0%), venous thrombosis (1% vs 0%), urine leakage (0.5% vs 1.9%), ureteral stenosis (0.5% vs 0%), reflux (0% vs 1.9%), lymphocele (11.7% vs 8.1%), and hernia (5.2% vs 8.1%), with no statistically significant differences shown between the groups. The living-donor group had graft and patient survival rates as high as the deceased-donor group. The low rate of morbidity and excellent survival rates make kidney transplant an excellent option for patients with polycystic kidney disease. Although fear of future appearance of polycystic kidney disease may reduce the rate of related living donors, our study showed that graft and patient survival rates in the living-donor group were as high as in the deceased-donor group.
- 1 January 2015
- Vol. 216, 1049
Integrating data from multiple sources for data completeness in a web-based registry for pediatric renal transplantation--the CERTAIN Registry.
Patient registries are a useful tool to measure outcomes and compare the effectiveness of therapies in a specific patient population. High data quality and completeness are therefore advantageous for registry analysis. Data integration from multiple sources may increase completeness of the data. The pediatric renal transplantation registry CERTAIN identified Eurotransplant (ET) and the Collaborative Transplant Study (CTS) as possible partners for data exchange. Import and export interfaces with CTS and ET were implemented. All parties reached their projected goals and benefit from the exchange.
- 1 January 2015
- Vol. 216, 1049
Integrating data from multiple sources for data completeness in a web-based registry for pediatric renal transplantation--the CERTAIN Registry.
Patient registries are a useful tool to measure outcomes and compare the effectiveness of therapies in a specific patient population. High data quality and completeness are therefore advantageous for registry analysis. Data integration from multiple sources may increase completeness of the data. The pediatric renal transplantation registry CERTAIN identified Eurotransplant (ET) and the Collaborative Transplant Study (CTS) as possible partners for data exchange. Import and export interfaces with CTS and ET were implemented. All parties reached their projected goals and benefit from the exchange.
- 21 May 2007
- p. 15-8
[When should you suspect meningitis?].
Bacterial meningitis is a life-threatening disease with a high mortality if left untreated. School-age children, adolescents and adults often present with typical symptoms such as fever, headache, neck stiffness and altered mental status, whereas infants show rather unspecific symptoms.The important task of the primary physician is to recognize the life-threatening condition in time and to refer the patient immediately to the next hospital.
- 21 May 2007
- p. 15-8
[When should you suspect meningitis?].
Bacterial meningitis is a life-threatening disease with a high mortality if left untreated. School-age children, adolescents and adults often present with typical symptoms such as fever, headache, neck stiffness and altered mental status, whereas infants show rather unspecific symptoms.The important task of the primary physician is to recognize the life-threatening condition in time and to refer the patient immediately to the next hospital.
- 4 February 2005
- Published by Springer Nature in Pediatric Nephrology
- Vol. 20 (3) , 279-289
Growth hormone/insulin-like growth factor system in children with chronic renal failure
Disturbances of the somatotropic hormone axis play an important pathogenic role in growth retardation and catabolism in children with chronic renal failure (CRF). The apparent discrepancy between normal or elevated growth hormone (GH) levels and diminished longitudinal growth in CRF has led to the concept of GH insensitivity, which is caused by multiple alterations in the distal components of the somatotropic hormone axis. Serum levels of IGF-I and IGF-II are normal in preterminal CRF, while in end-stage renal disease (ESRD) IGF-I levels are slightly decreased and IGF-II levels slightly increased. In view of the prevailing elevated GH levels in ESRD, these serum IGF-I levels appear inadequately low. Indeed, there is both clinical and experimental evidence for decreased hepatic production of IGF-I in CRF. This hepatic insensitivity to the action of GH may be partly the consequence of reduced GH receptor expression in liver tissue and partly a consequence of disturbed GH receptor signaling. The actions and metabolism of IGFs are modulated by specific high-affinity IGFBPs. CRF serum has an IGF-binding capacity that is increased by seven- to tenfold, leading to decreased IGF bioactivity of CRF serum despite normal total IGF levels. Serum levels of intact IGFBP-1, -2, -4, -6 and low molecular weight fragments of IGFBP-3 are elevated in CRF serum in relation to the degree of renal dysfunction, whereas serum levels of intact IGFBP-3 are normal. Levels of immunoreactive IGFBP-5 are not altered in CRF serum, but the majority of IGFBP-5 is fragmented. Decreased renal filtration and increased hepatic production of IGFBP-1 and -2 both contribute to high levels of serum IGFBP. Experimental and clinical evidence suggests that these excessive high-affinity IGFBPs in CRF serum inhibit IGF action in growth plate chondrocytes by competition with the type 1 IGF receptor for IGF binding. These data indicate that growth failure in CRF is mainly due to functional IGF deficiency. Combined therapy with rhGH and rhIGF-I is therefore a logical approach.
- 4 February 2005
- Published by Springer Nature in Pediatric Nephrology
- Vol. 20 (3) , 279-289
Growth hormone/insulin-like growth factor system in children with chronic renal failure
Disturbances of the somatotropic hormone axis play an important pathogenic role in growth retardation and catabolism in children with chronic renal failure (CRF). The apparent discrepancy between normal or elevated growth hormone (GH) levels and diminished longitudinal growth in CRF has led to the concept of GH insensitivity, which is caused by multiple alterations in the distal components of the somatotropic hormone axis. Serum levels of IGF-I and IGF-II are normal in preterminal CRF, while in end-stage renal disease (ESRD) IGF-I levels are slightly decreased and IGF-II levels slightly increased. In view of the prevailing elevated GH levels in ESRD, these serum IGF-I levels appear inadequately low. Indeed, there is both clinical and experimental evidence for decreased hepatic production of IGF-I in CRF. This hepatic insensitivity to the action of GH may be partly the consequence of reduced GH receptor expression in liver tissue and partly a consequence of disturbed GH receptor signaling. The actions and metabolism of IGFs are modulated by specific high-affinity IGFBPs. CRF serum has an IGF-binding capacity that is increased by seven- to tenfold, leading to decreased IGF bioactivity of CRF serum despite normal total IGF levels. Serum levels of intact IGFBP-1, -2, -4, -6 and low molecular weight fragments of IGFBP-3 are elevated in CRF serum in relation to the degree of renal dysfunction, whereas serum levels of intact IGFBP-3 are normal. Levels of immunoreactive IGFBP-5 are not altered in CRF serum, but the majority of IGFBP-5 is fragmented. Decreased renal filtration and increased hepatic production of IGFBP-1 and -2 both contribute to high levels of serum IGFBP. Experimental and clinical evidence suggests that these excessive high-affinity IGFBPs in CRF serum inhibit IGF action in growth plate chondrocytes by competition with the type 1 IGF receptor for IGF binding. These data indicate that growth failure in CRF is mainly due to functional IGF deficiency. Combined therapy with rhGH and rhIGF-I is therefore a logical approach.
- 3 February 2005
- Published by Springer Nature in Pediatric Nephrology
- Vol. 20 (3) , 249-250
IPNA Seventh Symposium on Growth and Development in Children with Chronic Kidney Disease: The Molecular Basis of Skeletal Growth
- 3 February 2005
- Published by Springer Nature in Pediatric Nephrology
- Vol. 20 (3) , 249-250
IPNA Seventh Symposium on Growth and Development in Children with Chronic Kidney Disease: The Molecular Basis of Skeletal Growth
- 1 October 2004
- Published by Elsevier in Kidney International
- Vol. 66 (4) , 1694-1706
Analysis of the functional muscle-bone unit of the forearm in pediatric renal transplant recipients
- 1 October 2004
- Published by Elsevier in Kidney International
- Vol. 66 (4) , 1694-1706
Analysis of the functional muscle-bone unit of the forearm in pediatric renal transplant recipients
- 12 February 2004
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (4) , 365-8
Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
- 12 February 2004
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (4) , 365-8
Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
- 1 January 2004
- Vol. 107, 921-5
CAMPUS--a flexible, interactive system for web-based, problem-based learning in health care.
Care for patients is the best way to learn medicine and medical methods and skills. But the availability of real patients for learners is limited. Often the appropriate patient is missed or he can not be demonstrated to all students because of practical or ethical problems. A possible solution is the presentation of a clinical problem by a virtual patient using a simulative computer program. But such an approach means often a lot of work for the author of the case. We developed a flexible and realistic system, CAMPUS (www.medicase.de), which supports the case authors with appropriate vocabularies and a comfortable authoring tool. There are different kinds of case presentations to the users in accordance to the level of professionalism of the user and the scenario the program is used in. An evaluation within an internship has shown, that such pro-grams are judged as useful by medical students. But further studies are necessary to examine if the program will be used for the self-study and to develop further kinds of using scenarios within problem-based curricula.
- 1 January 2004
- Vol. 107, 921-5
CAMPUS--a flexible, interactive system for web-based, problem-based learning in health care.
Care for patients is the best way to learn medicine and medical methods and skills. But the availability of real patients for learners is limited. Often the appropriate patient is missed or he can not be demonstrated to all students because of practical or ethical problems. A possible solution is the presentation of a clinical problem by a virtual patient using a simulative computer program. But such an approach means often a lot of work for the author of the case. We developed a flexible and realistic system, CAMPUS (www.medicase.de), which supports the case authors with appropriate vocabularies and a comfortable authoring tool. There are different kinds of case presentations to the users in accordance to the level of professionalism of the user and the scenario the program is used in. An evaluation within an internship has shown, that such pro-grams are judged as useful by medical students. But further studies are necessary to examine if the program will be used for the self-study and to develop further kinds of using scenarios within problem-based curricula.
- 1 January 2004
- Published by Georg Thieme Verlag KG in Kinder- und Jugendmedizin
- Vol. 04 (01) , 31-38
Stellenwert des interaktiven fallbasierten Computerlehr-/lernprogramms CAMPUS-Pädiatrie für die Aus- und Weiterbildung in der Kinderheilkunde und Jugendmedizin
Zusammenfassung: CAMPUS-Pädiatrie ist ein vom MWK Baden-Württemberg und vom BMBF (Bonn) gefördertes Forschungsprojekt zur Implementierung von fallbasiertem Training in der Kinderheilkunde. CAMPUS wurde primär für das studentische Selbstlernen und Praktika konzipiert, kann jedoch in modifizierter Form auch für den POL-Unterricht sowie für die Weiter- und Fortbildung eingesetzt werden. Ziel dieses interaktiven, problemorientierten und fallbasierten Computerlehr-/lernprogramms ist das Einüben von Lösungsstrategien anhand medizinischer Kasuistiken. Hierzu nimmt der Anwender die Rolle des Arztes ein und betreut selbständig einen Patienten in einer virtuellen Kinderklinik, indem er Anamnese erhebt, Untersuchungen durchführt und Diagnose- und Therapieentscheidungen trifft. CAMPUS-Pädiatrie ist seit dem Wintersemester 2000 in das Curriculum der Universitätskinderklinik Heidelberg integriert. Nach den bisherigen Erfahrungen im Studentenunterricht und den Ergebnissen einer im SS 2001 durchgeführten Evaluation ist CAMPUS-Pädiatrie eine geeignete Ergänzung des klassischen Lehrangebotes für die Kinderheilkunde. Im Rahmen des Verbundprojektes CASEPORT ist geplant, über ein bundesweites Internetportal eine übergreifende Lern- und Lehrplattform für die Kinderheilkunde aufzubauen, die künftig allen medizinischen Fakultäten zur Verfügung stehen soll.
- 1 January 2004
- Published by Georg Thieme Verlag KG in Kinder- und Jugendmedizin
- Vol. 04 (01) , 31-38
Stellenwert des interaktiven fallbasierten Computerlehr-/lernprogramms CAMPUS-Pädiatrie für die Aus- und Weiterbildung in der Kinderheilkunde und Jugendmedizin
Zusammenfassung: CAMPUS-Pädiatrie ist ein vom MWK Baden-Württemberg und vom BMBF (Bonn) gefördertes Forschungsprojekt zur Implementierung von fallbasiertem Training in der Kinderheilkunde. CAMPUS wurde primär für das studentische Selbstlernen und Praktika konzipiert, kann jedoch in modifizierter Form auch für den POL-Unterricht sowie für die Weiter- und Fortbildung eingesetzt werden. Ziel dieses interaktiven, problemorientierten und fallbasierten Computerlehr-/lernprogramms ist das Einüben von Lösungsstrategien anhand medizinischer Kasuistiken. Hierzu nimmt der Anwender die Rolle des Arztes ein und betreut selbständig einen Patienten in einer virtuellen Kinderklinik, indem er Anamnese erhebt, Untersuchungen durchführt und Diagnose- und Therapieentscheidungen trifft. CAMPUS-Pädiatrie ist seit dem Wintersemester 2000 in das Curriculum der Universitätskinderklinik Heidelberg integriert. Nach den bisherigen Erfahrungen im Studentenunterricht und den Ergebnissen einer im SS 2001 durchgeführten Evaluation ist CAMPUS-Pädiatrie eine geeignete Ergänzung des klassischen Lehrangebotes für die Kinderheilkunde. Im Rahmen des Verbundprojektes CASEPORT ist geplant, über ein bundesweites Internetportal eine übergreifende Lern- und Lehrplattform für die Kinderheilkunde aufzubauen, die künftig allen medizinischen Fakultäten zur Verfügung stehen soll.